Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?

被引:5
|
作者
Gaddas, M. [1 ]
Chaouache, N. [1 ]
Ajina, M. [2 ]
Tabka, Z. [1 ]
Ajina, M. Zaouali [1 ]
机构
[1] Fac Med Ibn el Jazzar, Lab Physiol & Explorat Fonct, Ave Mohamed Karoui, Sousse 4000, Tunisia
[2] CHU Farhat Hached, Unite Med Reprod, Ave Ibn el Jazzar, Sousse 4000, Tunisia
关键词
Hyperandrogenism; IVF; Polycystic ovarian; syndrome; SYNDROME PCOS; ANDROGEN RECEPTORS; INSULIN-RESISTANCE; DOWN-REGULATION; WOMEN; TESTOSTERONE; CYCLES; CELL; STIMULATION; APOPTOSIS;
D O I
10.1016/j.jgyn.2016.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV). Materials and methods. It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups. Results. SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response. Conclusion. Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [21] Impact of Central Obesity on Women with Polycystic Ovary Syndrome Undergoing In Vitro Fertilization
    Li, Yu
    Lin, Haiyan
    Pan, Ping
    Yang, Dongzi
    Zhang, Qingxue
    BIORESEARCH OPEN ACCESS, 2018, 7 (01): : 116 - 122
  • [22] Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome
    Kalem, Muberra Namli
    Kalem, Ziya
    Sari, Tamer
    Ates, Can
    Gurgan, Timur
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2016, 17 (02) : 83 - 90
  • [23] In vitro fertilization outcomes in women with polycystic ovary syndrome: A meta-analysis
    Tang, Kefu
    Wu, Lei
    Luo, Ying
    Gong, Bo
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 259 : 146 - 152
  • [24] A Mature Cystic Teratoma on the Ovary Does Not Alter in Vitro Fertilization Success Rate
    Hernandez-Nieto, Carlos
    Alkon, Tamar
    Lee, Joseph
    Gonzalez, Katherine
    Copperman, Alan B.
    Sandler, Benjamin
    OBSTETRICS AND GYNECOLOGY, 2019, 133 : 128S - 128S
  • [25] Comparison of in vitro maturation and in vitro fertilization for polycystic ovary syndrome patients-reply letter
    Xu, Yalan
    Qiao, Jie
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (09)
  • [26] Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor
    Nejad, Ensieh Shahrokh Tehrani
    Saedi, Tahereh
    Saedi, Sedigheh
    Rashidi, Batool Hossein
    Nekoo, Zahra Azimi
    Jahangiri, Nadia
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (02) : 117 - 120
  • [27] Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome
    Persson, Sofia
    Elenis, Evangelia
    Turkmen, Sahruh
    Kramer, Michael S.
    Yong, Eu-Leong
    Poromaa, Inger Sundstrom
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 : 66 - 66
  • [28] New insights into steroidogenesis in normo- and hyperandrogenic polycystic ovary syndrome patients
    de Medeiros, Sebastiao Freitas
    Gil-Junior, Angelo Barrionuevo
    Barbosa, Jacklyne Silva
    Isaias, Erico Duarte
    Winck Yamamoto, Marcia Marly
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2013, 57 (06) : 437 - 444
  • [29] Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome
    Persson, Sofia
    Elenis, Evangelia
    Turkmen, Sahruh
    Kramer, Michael S.
    Yong, Eu-Leong
    Poromaa, Inger Sundstrom
    FERTILITY AND STERILITY, 2021, 116 (03) : 862 - 871
  • [30] Macroprolactinemia in women presenting with hyperandrogenic symptoms: implications for the management of polycystic ovary syndrome
    Escobar-Morreale, HF
    FERTILITY AND STERILITY, 2004, 82 (06) : 1697 - 1699